Adoption of Lutetium-177 PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020

被引：0
|
作者：
Luka Flegar
Smita George Thoduka
Damiano Librizzi
Markus Luster
Aristeidis Zacharis
Hendrik Heers
Nicole Eisenmenger
Hojjat Ahmadzadehfar
Matthias Eiber
Wolfgang Weber
Christer Groeben
Johannes Huber
机构：
[1] Philipps-University Marburg,Department of Urology
[2] Philipps-University Marburg,Department of Nuclear Medicine
[3] Reimbursement Institute,Department of Nuclear Medicine
[4] Klinikum Westfalen GmbH,Department of Nuclear Medicine
[5] Technische Universität Munich,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷
关键词：
Prostate cancer; mCRPC; Lutetium-; PSMA (; Lu-PSMA); Radioligand therapy; Health services research; Trends;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2188 / 2195
页数：7
相关论文
共 50 条
  • [31] Treatment efficacy and safety of 177Lu-PSMA Radioligand Therapy in Octogenarians with metastatic castration-resistant prostate cancer
    Langbein, T.
    Retz, M.
    D'Alessandria, C.
    Grigorascu, S.
    Hansen, K.
    Wester, H.
    Gschwend, J.
    Weber, W.
    Eiber, M.
    Tauber, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S132 - S133
  • [32] 177Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate Cancer
    Zang, Jie
    Liu, Qingxing
    Sui, Huimin
    Wang, Rongxi
    Jacobson, Orit
    Fan, Xinrong
    Zhu, Zhaohui
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (12) : 1772 - 1778
  • [33] Efficacy and Safety of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients
    Yadav, Madhav Prasad
    Ballal, Sanjana
    Bal, Chandrashekhar
    Sahoo, Ranjit Kumar
    Damle, Nishikant Avinash
    Tripathi, Madhavi
    Seth, Amlesh
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : 19 - 31
  • [34] 177Lu-EB-PSMA radioligand therapy with escalating doses in patients with metastatic castration-resistant prostate cancer
    Zang, Jie
    Liu, Qingxing
    Sui, Huimin
    Wang, Rongxi
    Jacobson, Orit
    Zhu, Zhaohui
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [35] Re-Rechallenge 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
    Aggarwal, Piyush
    Gunasekaran, Vinisha
    Sood, Ashwani
    Kumar, Narendra
    Rathore, Yogesh
    Kumar, Rajender
    Mittal, Bhagwant Rai
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (03) : 231 - 233
  • [36] Radioligand Therapy with 177Lu-PSMA in Metastatic Castration Resistant Prostate Cancer Patients: First case series in Iran
    Aryana, K.
    Moghadam, S. Zarehparvar
    Divband, G. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S649 - S650
  • [37] Antitumor activity of repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
    Rahbar, Kambiz
    Braeuer, Axel
    Yordanova, Anna
    Boegemann, Martin
    Hauser, Stefan
    Eveslage, Maria
    Essler, Markus
    Schafers, Michael
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [38] CLINICAL EXPERIENCE WITH LUTETIUM 177-LABELED PSMA-I&T FOR RADIOLIGAND THERAPY IN 100 CONSECUTIVE PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Heck, Matthias
    Schwaiger, Sebastian
    Knorr, Karina
    Retz, Margitta
    Maurer, Tobias
    Janssen, Friederike
    D'Alessandria, Calogero
    Wester, Hans-Juergen
    Gschwend, Juergen
    Schwaiger, Markus
    Tauber, Robert
    Eiber, Matthias
    JOURNAL OF UROLOGY, 2018, 199 (04): : E304 - E304
  • [39] Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Daniel Groener
    Cam Tu Nguyen
    Justus Baumgarten
    Benjamin Bockisch
    Karen Davis
    Christian Happel
    Nicolai Mader
    Christina Nguyen Ngoc
    Jennifer Wichert
    Severine Banek
    Philipp Mandel
    Felix K. H. Chun
    Nikolaos Tselis
    Frank Grünwald
    Amir Sabet
    EJNMMI Research, 11
  • [40] Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Groener, Daniel
    Cam Tu Nguyen
    Baumgarten, Justus
    Bockisch, Benjamin
    Davis, Karen
    Happel, Christian
    Mader, Nicolai
    Ngoc, Christina Nguyen
    Wichert, Jennifer
    Banek, Severine
    Mandel, Philipp
    Chun, Felix K. H.
    Tselis, Nikolaos
    Gruenwald, Frank
    Sabet, Amir
    EJNMMI RESEARCH, 2021, 11 (01)
12345